These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1183217)

  • 1. Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis.
    Kennedy AC; Allam BF; Boyle IT; Nuki G; Rooney PJ; Buchanan WW
    Curr Med Res Opin; 1975; 3(6):345-58. PubMed ID: 1183217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism in postmenopausal women with active rheumatoid arthritis.
    Verstraeten A; Dequeker J
    J Rheumatol; 1986 Feb; 13(1):43-6. PubMed ID: 3701743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?
    Als OS; Gotfredsen A; Riis BJ; Christiansen C
    Ann Rheum Dis; 1985 Jun; 44(6):406-11. PubMed ID: 3874608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ionized calcium: some factors influencing its level.
    Pittinger C; Chang PM; Faulkner W
    South Med J; 1971 Oct; 64(10):1211-5. PubMed ID: 5097795
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications.
    Kennedy AC; Allam RF; Rooney PJ; Watson ME; Fairney A; Buchanan KD; Hillyard CJ
    Ann Rheum Dis; 1979 Oct; 38(5):401-12. PubMed ID: 518139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.
    Als OS; Christiansen C; Hellesen C
    Clin Rheumatol; 1984 Jun; 3(2):201-8. PubMed ID: 6467862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical abnormalities in anorexia nervosa and bulimia.
    Mira M; Stewart PM; Vizzard J; Abraham S
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():29-35. PubMed ID: 3103518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarks in secondary osteoporosis.
    Aroso Dias A; Lopes Vaz A; Hargreaves M; Afonso C; Araújø D; Bravo T
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():89-94. PubMed ID: 2758783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of bone changes in patients with rheumatoid arthritis.
    Perlík F; Kůtová M
    Z Rheumatol; 1983; 42(5):261-4. PubMed ID: 6649934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intra- and interindividual variation on the appropriate use of normal ranges.
    Harris EK
    Clin Chem; 1974 Dec; 20(12):1535-42. PubMed ID: 4430131
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
    Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
    Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metabolism and rheumatoid arthritis].
    Seidel A
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:258-65. PubMed ID: 5051951
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary hyperparathyroidism: clinical and biochemical features.
    Mallette LE; Bilezikian JP; Heath DA; Aurbach GD
    Medicine (Baltimore); 1974 Mar; 53(2):127-46. PubMed ID: 4361513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency, spontaneous fractures, and osteopenia in rheumatoid arthritis.
    Maddison PJ; Bacon PA
    Br Med J; 1974 Nov; 4(5942):433-5. PubMed ID: 4425914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in rheumatoid arthritis measured by the gamma transmission method.
    Oka M; Rekonen A; Kuikka J; Anttinen J
    Scand J Rheumatol; 1975; 4(1):28-32. PubMed ID: 1153977
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.